Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan So

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 4, 2013
Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in CanadaMichael Metcalfe, Wassim Kassouf, Ricardo Rendon, et al.
European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urologic Oncology|May 27, 2014
Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract CollaborationVincent Fradet, Julian Mauermann, Wassim Kassouf, et al.
World Journal of Urology|July 23, 2016
Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional studyNarhari Timilshina, Veronique Ouellet, Shabbir M H Alibhai, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 4, 2017
Structured assessment and followup for patients with hereditary kidney tumour syndromesJean-Baptiste Lattouf, Stephen E Pautler, M Neil Reaume, et al.
European Urology|March 6, 2017
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate CancerMatti Annala, Werner J Struss, Evan W Warner, et al.
Urologic Oncology|February 19, 2013
Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinomaAndrew K Williams, Wassim Kassouf, Joseph Chin, et al.
The Journal of Urology|July 3, 2020
Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell CarcinomaBenjamin Shiff, Rodney H Breau, Premal Patel, et al.
Urologic Oncology|February 23, 2013
Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcomeFaysal A Yafi, Simon Tanguay, Ricardo Rendon, et al.
The Journal of Urology|November 10, 2020
Reply By AuthorsBenjamin Shiff, Rodney H Breau, Premal Patel, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|January 4, 2013
Regional differences in practice patterns and associated outcomes for upper tract urothelial carcinoma in CanadaMichael Metcalfe, Wassim Kassouf, Ricardo Rendon, et al.
European Urology Open Science|August 2, 2021
WATER versus WATER II 2-Year Update: Comparing Aquablation Therapy for Benign Prostatic Hyperplasia in 30-80-cm<sup>3</sup> and 80-150-cm<sup>3</sup> ProstatesDavid-Dan Nguyen, Neil Barber, Mo Bidair, et al.
Urologic Oncology|May 27, 2014
Risk factors for bladder cancer recurrence after nephroureterectomy for upper tract urothelial tumors: results from the Canadian Upper Tract CollaborationVincent Fradet, Julian Mauermann, Wassim Kassouf, et al.
World Journal of Urology|July 23, 2016
Analysis of active surveillance uptake for low-risk localized prostate cancer in Canada: a Canadian multi-institutional studyNarhari Timilshina, Veronique Ouellet, Shabbir M H Alibhai, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|March 4, 2017
Structured assessment and followup for patients with hereditary kidney tumour syndromesJean-Baptiste Lattouf, Stephen E Pautler, M Neil Reaume, et al.
European Urology|March 6, 2017
Treatment Outcomes and Tumor Loss of Heterozygosity in Germline DNA Repair-deficient Prostate CancerMatti Annala, Werner J Struss, Evan W Warner, et al.
Urologic Oncology|February 19, 2013
Multifocality rather than tumor location is a prognostic factor in upper tract urothelial carcinomaAndrew K Williams, Wassim Kassouf, Joseph Chin, et al.
The Journal of Urology|July 3, 2020
Impact of Time to Surgery and Surgical Delay on Oncologic Outcomes for Renal Cell CarcinomaBenjamin Shiff, Rodney H Breau, Premal Patel, et al.
Urologic Oncology|February 23, 2013
Adjuvant chemotherapy for upper-tract urothelial carcinoma treated with nephroureterectomy: assessment of adequate renal function and influence on outcomeFaysal A Yafi, Simon Tanguay, Ricardo Rendon, et al.
The Journal of Urology|November 10, 2020
Reply By AuthorsBenjamin Shiff, Rodney H Breau, Premal Patel, et al.
Pageof 13